Need a cheat sheet to help keep it all straight? The CDC thinks you should remember 10 easy bullet points about this surprisingly complex disease. Here they are:
1. There are five “types” of meningitis.
Meningitis may develop in response to a number of causes, usually bacteria or viruses, but meningitis can also be caused by physical injury, cancer or certain drugs.
The five “types” of meningitis are:
- Bacterial Meningitis
- Viral Meningitis
- Fungal Meningitis
- Parasitic Meningitis
- Non-infectious Meningitis
The severity of illness and the treatment for meningitis differ depending on the cause. Thus, it is important to know the specific cause of meningitis. For the ongoing outbreak of fungal meningitis and other infections linked to contaminated steroid medication, fungus was discovered as the cause. More on that below. But let’s first look at some of the other types of meningitis and facts you need to know.
2. There are vaccines that protect against three types of bacteria that can cause meningitis.
Bacterial meningitis is usually severe and can be life-threatening. While most people with meningitis recover, it can cause serious complications, such as brain damage, hearing loss or learning disabilities. In the United States, about 4,100 cases of bacterial meningitis, including 500 deaths, occurred each year between 2003-2007.
The germs that cause bacterial meningitis can be contagious. Some bacteria can spread through the exchange of respiratory and throat secretions (e.g., kissing). Fortunately, most of the bacteria that cause bacterial meningitis are not as contagious as diseases like the common cold or the flu. Also, the bacteria are not spread by casual contact or by simply breathing the air where a person with meningitis has been.
Other meningitis-causing bacteria are not spread person-to-person, but can cause disease because the person has certain risk factors (such as a weak immune system or head trauma). And finally, unlike other bacterial causes of meningitis, you can get Listeria monocytogenes by eating contaminated food.
The most effective way to protect you and your child against certain types of bacterial meningitis is to complete the recommended vaccine schedule. There are vaccines for three types of bacteria that can cause meningitis: Neisseria meningitidis (meningococcus), Streptococcus pneumoniae (pneumococcus), and Haemophilus influenzae type b (Hib).
3. There are things that can increase your risk of bacterial meningitis.
Factors that can increase your risk of bacterial meningitis include:
Age: Infants are at higher risk for bacterial meningitis than people in other age groups. However, people of any age are at risk.
Community setting: Infectious diseases tend to spread more quickly where larger groups of people gather together. College students living in dormitories and military personnel are at increased risk for meningococcal meningitis.
Certain medical conditions: There are certain diseases, medications, and surgical procedures that may weaken the immune system or increase risk of meningitis in other ways.
Working with meningitis-causing pathogens: Microbiologists who are routinely exposed to meningitis-causing pathogens are at increased risk.
Travel: Travelers to the meningitis belt in sub-Saharan Africa may be at risk for meningococcal meningitis, particularly during the dry season. Also at risk for meningococcal meningitis are travelers to Mecca during the annual Hajj and Umrah pilgrimage.
Bacterial meningitis infection may show up in a person by a sudden onset of fever, headache, and stiff neck. It will often have other symptoms, such as nausea, vomiting, increased sensitivity to light, and confusion. Infants may appear to be slow or inactive (lack of alertness), irritable, vomiting or feeding poorly. The symptoms of bacterial meningitis can appear quickly or over several days. Typically they develop within three to seven days after exposure. Later symptoms of bacterial meningitis can be very severe (e.g., seizures, coma). For this reason, anyone who thinks they may have meningitis should see a doctor as soon as possible.
Bacterial meningitis can be treated effectively with antibiotics. It is important that treatment be started as soon as possible. Appropriate antibiotic treatment of the most common types of bacterial meningitis should reduce the risk of dying from meningitis to below 15 percent, although the risk remains higher among young infants and the elderly.
4. Symptoms of viral meningitis in adults may differ from those in children.
Viral meningitis is generally less severe and resolves without specific treatment. However, the symptoms of viral meningitis are similar to those for bacterial meningitis, which can be fatal. Because of this, it is important to see a health care provider right away if you think you or your child might have meningitis.
Common symptoms in infants:
- Poor eating
- Hard to awaken
Common symptoms in adults:
- High fever
- Severe headache
- Stiff neck
- Sensitivity to bright light
- Sleepiness or trouble waking up
- Nausea, vomiting
- Lack of appetite
There is no specific treatment for viral meningitis. Antibiotics do not help viral infections, so they are not useful in the treatment of viral meningitis. Symptoms usually last from seven to 10 days, and people with normal immune systems usually recover completely. A hospital stay may be necessary in more severe cases or for people with weak immune systems.
5. There are no vaccines for the most common causes of viral meningitis, so the best way to prevent it is to prevent viral infections.
Most viral meningitis cases in the United States, especially during the summer months, are caused by enteroviruses (small viruses made of RNA and protein); however, only a small number of people with enterovirus infections actually develop meningitis.
There are steps you can take to help lower your chances of becoming infected with viruses or of passing one on to someone else:
- Wash your hands thoroughly and often, especially after changing diapers, using the toilet, or coughing or blowing your nose.
- Clean contaminated surfaces, such as doorknobs or the TV remote control, with soap and water and then disinfect them with a dilute solution of chlorine-containing bleach.
- Avoid kissing or sharing a drinking glass, eating utensil, lipstick, or other such items with sick people or with others when you are sick.
- Make sure you and your child are vaccinated. Vaccinations included in the childhood vaccination schedule can protect children against some diseases that can lead to viral meningitis. These include vaccines against measles and mumps (MMR vaccine) and chickenpox (varicella-zoster vaccine).
- Avoid bites from mosquitoes and other insects that carry diseases that can infect humans.
- Control mice and rats. If you have a rodent infestation in and/or around your home, follow the cleaning and control precautions listed on CDC’s website about LCMV (Lymphocytic choriomeningitis virus). In rare cases LCMV, which is spread by rodents, can cause viral meningitis.
6. Fungal meningitis is very rare in the United States, but is more common in places such as sub-Saharan Africa.
Although anyone can get fungal meningitis, people with weak immune systems, like those with AIDS or cancer, are at higher risk. The most common cause of fungal meningitis for people with weak immune systems is Cryptococcus. This disease is one of the most common causes of adult meningitis in Africa.
CDC is currently working with countries in Africa and Asia to begin screening for Cryptococcus. We have new rapid diagnostic tests that will allow clinicians to detect fungal meningitis early among HIV positive patients, which will help them receive treatment earlier and has the potential to save hundreds of thousands of lives. There are about a million cases of fungal meningitis in sub-Saharan Africa every year, and about 600,000 deaths — even more deaths than are caused by tuberculosis, so this screening has the potential to make a huge impact in these countries.
7. Fungal meningitis is not contagious.
Fungal meningitis is not transmitted from person to person. It can develop after a fungus spreads through the bloodstream from somewhere else in the body, as a result of the fungus being introduced directly into the central nervous system, or from an infected body site infection next to the central nervous system.
You may also get fungal meningitis after taking medications that weaken your immune system. Examples of these medications include steroids (such as prednisone), medications given after organ transplantation, or anti-TNF medications, which are sometimes given for treatment of rheumatoid arthritis or other autoimmune conditions.
Symptoms are similar to symptoms of other forms of meningitis; however, they often appear more gradually and can be very mild at first.
Fungal meningitis is treated with long courses of high-dose antifungal medications, usually given through an IV line in the hospital. The length of treatment depends on the status of the immune system and the type of fungus that caused the infection. For people with immune systems that do not function well because of other conditions, like AIDS, diabetes, or cancer, treatment is often longer.
8. The United States is currently experiencing an unprecedented multi-state outbreak of fungal meningitis and other infections.
The Centers for Disease Control and Prevention (CDC), in collaboration with state and local health departments and the Food and Drug Administration (FDA), is investigating a multistate outbreak of fungal meningitis and other infections among patients who received contaminated steroid injections. The infections identified as part of this investigation include fungal meningitis, a form of meningitis that is not contagious, and infections associated with injections in a peripheral joint space, such as a knee, shoulder, or ankle.
All of the infections were associated with one of three lots of preservative-free methylprednisolone acetate, an injectable steroid medication recalled on September 26, 2012, from the New England Compounding Center (NECC). See CDC’s website for more information about what patients need to know.
9. Primary amebic meningoencephalitis (PAM) is a very rare form of parasitic meningitis that causes a fatal brain infection.
Primary amebic meningoencephalitis (PAM) is a very rare form of parasitic meningitis that is caused by the microscopic ameba (a single-celled living organism) Naegleria fowleri.
Naegleria fowleri infects people by entering the body through the nose. This typically occurs when people go swimming or diving in warm freshwater places, like lakes and rivers. The Naegleria fowleri ameba travels up the nose to the brain where it destroys the brain tissue.
No data exist to accurately estimate the true risk of PAM. The hundreds of millions of visits to swimming venues that occur each year in the U.S. result in 0-8 infections per year.
Naegleria fowleri is found around the world. In the United States, the majority of infections have been caused by Naegleria fowleri from warm freshwater located in southern-tier states. The ameba can be found in:
- Bodies of warm freshwater, such as lakes and rivers
- Geothermal (naturally hot) water, such as hot springs
- Warm water discharge from industrial plants
- Geothermal (naturally hot) drinking water sources
- Swimming pools that are poorly maintained, minimally-chlorinated, and/or un-chlorinated
- Water heaters with temperatures less than 116.6 degrees Fahrenheit (47 degrees Celsius).
Naegleria fowleri is not found in salt water, like the ocean.
Several drugs are effective against Naegleria fowleri in the laboratory. However, their effectiveness is unclear since almost all infections have been fatal, even when people were treated. The fatality rate for an infected person who begins to show signs and symptoms is over 99 percent. Only 1 person out of 123 known infected individuals in the United States from 1962 to 2011 has survived.
10. There are several things that can cause non-infectious meningitis.
Non-infectious meningitis causes include:
- Systemic lupus erythematosus (lupus)
- Certain drugs
- Head injury
- Brain surgery
Treatment depends on the underlying cause (cancer, head injury, brain surgery, etc.).
This type of meningitis is not spread from person to person. Like other types of meningitis, symptoms of non-infectious meningitis include a sudden onset of fever, headache and stiff neck. It is often accompanied by other symptoms, such as nausea, vomiting, photophobia (sensitivity to light), and altered mental status.
If you still have questions about meningitis, join the NewsHour’s live chat with the CDC’s Dr. Amanda Cohn and Dr. Benjamin Park on Thursday, Nov. 15, at 1 p.m. ET. Submit your question in the comments section below or participate in the conversation live on Thursday.
DENVER – The department of Public Health and Environment is recalling grape tomatoes sold in Colorado due to Salmonella risk. The recalled tomatoes were used in pre-packaged salads made by Taylor Farms Pacific for several stores. However, in Colorado, only products sold at Safeway stores are included in the recall.
According to a Safeway representative, the recalled products were pulled from store shelves on Sat. April 30. No illnesses have been reported.
The following Signature Café products sold at Safeway stores in Colorado are included in the recall:
– Chef salad in 11-oz. plastic trays with use by dates of 4/30/2011-5/5/2011 and UPC code 21130-06252
– Cobb salad in12-oz. plastic trays with use by dates of 4/30/2011-5/3/2011 and UPC code 21130-06251
– Greek salad in 13.5 oz. plastic tray with use by dates of 4/30/2011-5/3/2011 and 4/30/2011-5/5/2011, and UPC code 21130-06257
– Tomato mozzarella salad (sold at the deli counter) in varying sizes with use by dates of 4/30/2011-5/6/2011, 4/30/2011-5/7/2011, and 4/30/2011-5/8/2011, and UPC code 21256300000
Anyone who purchased any of the recalled products is advised to discard it or return it to the place of purchase for a refund.
Salmonella is a food-borne bacteria which cause serious and sometimes fatal infections in children, elderly and others with weakened immune systems. Healthy people infected with Salmonella often experience fever, diarrhea, nausea, vomiting and abdominal pain.
| Known Cases and Outbreaks of Ebola Hemorrhagic Fever, in Chronological Order Source: http://www.cdc.gov/
Reported no. (%) of deaths among cases
|Download PDF version formatted for print (81 KB/7 pages)|
Biography: Jonas Salk Developer of Polio Vaccine Jonas Salk Date of birth: October 28, 1914 Jonas Salk Date of death: June 23, 1995 Back to Jonas Salk Biography In America in the 1950s, summertime was a time of fear and anxiety for many parents; this … by The American Academy of Achievement
In America in the 1950s, summertime was a time of fear and anxiety for many parents; this was the season when children by the thousands became infected with the crippling disease poliomyelitis, or polio. This burden of fear was lifted forever when it was announced that Dr. Jonas Salk had developed a vaccine against the disease. Salk became world-famous overnight, but his discovery was the result of many years of painstaking research.
Jonas Salk was born in New York City. His parents were Russian-Jewish immigrants who, although they themselves lacked formal education, were determined to see their children succeed, and encouraged them to study hard. Jonas Salk was the first member of his family to go to college. He entered the City College of New York intending to study law, but soon became intrigued by medical science.
While attending medical school at New York University, Salk was invited to spend a year researching influenza. The virus that causes flu had only recently been discovered and the young Salk was eager to learn if the virus could be deprived of its ability to infect, while still giving immunity to the illness. Salk succeeded in this attempt, which became the basis of his later work on polio.
After completing medical school and his internship, Salk returned to the study of influenza, the flu virus. World War II had begun, and public health experts feared a replay of the flu epidemic that had killed millions in the wake of the First World War. The development of vaccines controlled the spread of flu after the war and the epidemic of 1919 did not recur.
In 1947, Salk accepted an appointment to the University of Pittsburgh Medical School. While working there, with the National Foundation for Infantile Paralysis, Salk saw an opportunity to develop a vaccine against polio, and devoted himself to this work for the next eight years.
In 1955 Salk’s years of research paid off. Human trials of the polio vaccine effectively protected the subject from the polio virus. When news of the discovery was made public on April 12, 1955, Salk was hailed as a miracle worker. He further endeared himself to the public by refusing to patent the vaccine. He had no desire to profit personally from the discovery, but merely wished to see the vaccine disseminated as widely as possible.
Salk’s vaccine was composed of “killed” polio virus, which retained the ability to immunize without running the risk of infecting the patient. A few years later, a vaccine made from live polio virus was developed, which could be administered orally, while Salk’s vaccine required injection. Further, there was some evidence that the “killed” vaccine failed to completely immunize the patient. In the U.S., public health authorities elected to distribute the “live” oral vaccine instead of Salk’s. Tragically, the preparation of live virus infected some patients with the disease, rather than immunizing them. Since the introduction of the original vaccine, the few new cases of polio reported in the United States were probably caused by the “live” vaccine which was intended to prevent them.
In countries where Salk’s vaccine has remained in use, the disease has been virtually eradicated.
In 1963, Salk founded the Jonas Salk Institute for Biological Studies, an innovative center for medical and scientific research. Jonas Salk continued to conduct research and publish books, some written in collaboration with one or more of his sons, who are also medical scientists.
Salk’s published books include Man Unfolding (1972), The Survival of the Wisest(1973), World Population and Human Values: A New Reality (1981), and Anatomy of Reality (1983).
Dr. Salk’s last years were spent searching for a vaccine against AIDS. Jonas Salk died on June 23, 1995. He was 80 years old.
In the summer of 1950 fear gripped the residents of Wytheville, Virginia. Movie theaters shut down, baseball games were cancelled and panicky parents kept their children indoors — anything to keep them safe from an invisible invader. Outsiders sped t…
American Experience: The Polio Crusade
Airs Monday, April 12, 2010 at 9 p.m. on KPBS TV
Credit: March of Dimes
Above: Nurse and child with polio. This program is the story of the largest public health experiment in American history — the effort to eradicate polio, one of the 20th-century’s most dreaded diseases.
April 9, 2010
It was the largest public health experiment in American history – a crusade that eradicated polio, one of the 20th century’s most dreaded diseases. The polio epidemic terrified Americans for decades, affecting thousands of children, leaving many crippled, paralyzed or condemned to life in an iron lung.
In the mid-twentieth century, the National Foundation for Infantile Paralysis (predecessor to today’s March of Dimes) pioneered a new approach to philanthropy, raising money a dime at a time from millions of small donors. The nonprofit enlisted poster children, celebrities, presidents, and other partners in their high-profile campaigns. View the photos.
But on April 26, 1954, hope emerged. At the Franklin Sherman Elementary School in McLean, Virginia, six-year-old Randy Kerr stood at the head of a long line of children and waited patiently while a nurse gently rolled up his sleeve, then filled a syringe with a cherry-colored liquid containing the world’s first polio vaccine.
Developed just a few years earlier by virologist Jonas Salk, the polio vaccine had not yet been widely tested on humans. No one was certain it was safe or whether it could provide effective protection against the disease. In the coming weeks, nearly two million school children in 44 states received the shots. The Salk vaccine trials were the dramatic culmination of years of research and a multi-million dollar investment, made up in large part by public donations.
Based in part on David Oshinsky’s Pulitzer Prize-winning book, “Polio: An American Story,” “The Polio Crusade” chronicles a decades-long crusade, fueled by the bold leadership of a single philanthropy and its innovative public relations campaign, and features a bitter battle between two scientists and the breakthrough of a now-forgotten woman researcher.
The 20th-century effort to eradicate polio is chronicled. Included: lawyer Basil O’Connor (1892-1972), who developed the “March of Dimes” concept to help fund research; the competition between polio researchers Jonas Salk and Albert Sabin.